STAT3 is a convergent mediator of oncogenic signalling by numerous pathways, and constitutive activation of STAT3 inhibits the expression of anti‐tumour immune mediators, leading to an impaired immune response.108. The gene discussed is STAT3; the disease is neoplasm.